Drugs / para-Tyrosine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03278730 Comparator | Jan 2027 | infectious disease with sepsis | University of Pecs | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | para-Tyrosine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03278730 ↗ |
| Known as | P-Tyr | “supplementation of para-Tyrosine (p-Tyr) in the early phase of sepsis may diminish some specific inflammatory procedures” NCT03278730 ↗ |